Skin-mucous membrane disorder and therapeutic effect of pegylated liposomal doxorubicin in recurrent ovarian cancer.
Yuki YamadaRyuji KawaguchiFuminori ItoKana IwaiEmiko NiiroHiroshi ShigetomiYasuhito TanaseHiroshi KobayashiPublished in: The journal of obstetrics and gynaecology research (2017)
Severity of HFS and mucositis may be a predictive marker of PLD efficacy. The prevention and management of HFS and mucositis are important for continued treatment.